Qinghua Wang

2.6k total citations
89 papers, 1.6k citations indexed

About

Qinghua Wang is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Qinghua Wang has authored 89 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 25 papers in Molecular Biology and 22 papers in Surgery. Recurrent topics in Qinghua Wang's work include Cancer Immunotherapy and Biomarkers (20 papers), Pancreatic function and diabetes (12 papers) and Immunotherapy and Immune Responses (11 papers). Qinghua Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (20 papers), Pancreatic function and diabetes (12 papers) and Immunotherapy and Immune Responses (11 papers). Qinghua Wang collaborates with scholars based in China, Canada and United States. Qinghua Wang's co-authors include Nina Zhang, Tianru Jin, Kexin Chen, Xiangchun Li, Meng Yang, Gérald J. Prud’homme, Fengju Song, Yichen Yang, Toshiyuki Obata and Matthias Braun and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Qinghua Wang

82 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qinghua Wang China 22 582 502 351 224 221 89 1.6k
Zhiyong Gao United States 27 985 1.7× 768 1.5× 386 1.1× 248 1.1× 70 0.3× 49 1.9k
Rebeca Busto Spain 24 881 1.5× 252 0.5× 509 1.5× 208 0.9× 114 0.5× 59 1.7k
Jianling Xie Australia 25 1.0k 1.8× 173 0.3× 171 0.5× 164 0.7× 120 0.5× 55 1.8k
Seung‐Kuy Cha South Korea 24 1.1k 1.9× 287 0.6× 155 0.4× 80 0.4× 196 0.9× 55 2.5k
Valérie Robert France 24 1.6k 2.7× 523 1.0× 888 2.5× 136 0.6× 160 0.7× 44 2.8k
Nicola Perrotti Italy 30 1.4k 2.3× 352 0.7× 592 1.7× 228 1.0× 184 0.8× 92 2.4k
Youyi Dong Japan 27 806 1.4× 141 0.3× 487 1.4× 405 1.8× 76 0.3× 42 1.7k
Julie Venter United States 38 921 1.6× 1.5k 2.9× 222 0.6× 666 3.0× 175 0.8× 94 3.4k
Daniel Garcia United States 7 1.1k 1.9× 302 0.6× 231 0.7× 149 0.7× 67 0.3× 8 1.9k

Countries citing papers authored by Qinghua Wang

Since Specialization
Citations

This map shows the geographic impact of Qinghua Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinghua Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinghua Wang more than expected).

Fields of papers citing papers by Qinghua Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinghua Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinghua Wang. The network helps show where Qinghua Wang may publish in the future.

Co-authorship network of co-authors of Qinghua Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Qinghua Wang. A scholar is included among the top collaborators of Qinghua Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinghua Wang. Qinghua Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Jiahao, Kaihua Ji, Guangbo Kang, et al.. (2025). Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis. Pharmacological Research. 213. 107642–107642. 2 indexed citations
2.
Wang, Qinghua, et al.. (2025). Transcriptome sequencing elucidates the adaptation mechanisms of Pyrus betulifolia to cold and drought conditions. Plant Growth Regulation. 105(2). 463–478.
3.
Wang, Qinghua, et al.. (2025). Exposure–Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Treated with Metformin. Clinical Pharmacokinetics. 64(12). 1799–1809.
4.
Zhang, Jıng, Qinghua Wang, Ben‐Ben Miao, et al.. (2024). Liver transcriptome analysis reveal the metabolic and apoptotic responses of Trachinotus ovatus under acute cold stress. Fish & Shellfish Immunology. 148. 109476–109476. 6 indexed citations
5.
Yu, Xin, Juan Ge, Huimin Xie, et al.. (2024). MiR-483-3p promotes dental pulp stem cells osteogenic differentiation via the MAPK signaling pathway by targeting ARRB2. In Vitro Cellular & Developmental Biology - Animal. 60(8). 879–887. 2 indexed citations
6.
Wang, Qinghua, et al.. (2024). MRI‐based clinical‐radiomics nomogram model for predicting microvascular invasion in hepatocellular carcinoma. Medical Physics. 51(7). 4673–4686. 5 indexed citations
7.
Wang, Aimin, et al.. (2024). Lipoproteins and metabolites in diagnosing and predicting Alzheimer’s disease using machine learning. Lipids in Health and Disease. 23(1). 152–152. 3 indexed citations
8.
Wang, Qinghua, Wenjing Zhang, Yuxian Guo, et al.. (2023). A mutational signature and significantly mutated driver genes associated with immune checkpoint inhibitor response across multiple cancers. International Immunopharmacology. 116. 109821–109821. 2 indexed citations
9.
Li, Cheng‐Hui, et al.. (2023). The predictive model for risk of chemotherapy-induced thrombocytopenia based on antineoplastic drugs for solid tumors in eastern China. Scientific Reports. 13(1). 3185–3185. 5 indexed citations
10.
Zhang, Wenjing, Yujia Kong, Yuting Li, et al.. (2022). Novel Molecular Determinants of Response or Resistance to Immune Checkpoint Inhibitor Therapies in Melanoma. Frontiers in Immunology. 12. 798474–798474. 18 indexed citations
11.
Zhang, Wenjing, Fuyan Shi, Yujia Kong, et al.. (2021). Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer. Cancer Medicine. 11(3). 676–691. 25 indexed citations
12.
Wang, Qinghua, Juncheng Lyu, Wenjing Zhang, et al.. (2021). Immunological and clinical immunotherapy implications of NLRP3 mutations in melanoma. Aging. 13(21). 24271–24289. 11 indexed citations
13.
Wang, Qinghua, Jun Huang, Yubin Li, & Hugo K. Dooner. (2020). The unusual dRemp retrotransposon is abundant, highly mutagenic, and mobilized only in the second pollen mitosis of some maize lines. Proceedings of the National Academy of Sciences. 117(30). 18091–18098. 2 indexed citations
15.
Hong, Ling, Yunxiang Zhang, Qinghua Wang, Yibing Han, & Xiaoming Teng. (2016). Effects of interleukin 6 and tumor necrosis factor-α on the proliferation of porcine theca interna cells: Possible role of these cytokines in the pathogenesis of polycystic ovary syndrome. Taiwanese Journal of Obstetrics and Gynecology. 55(2). 183–187. 13 indexed citations
16.
Liu, Yu-Hui, Ye‐Ran Wang, Shu‐Sheng Jiao, et al.. (2015). Serum Aβ is Predictive for Short-Term Neurological Deficits After Acute Ischemic Stroke. Neurotoxicity Research. 27(3). 292–299. 17 indexed citations
17.
Liu, Rui, Duan Ma, Yiming Li, et al.. (2014). The anorexic effect of Ex4/Fc through GLP-1 receptor activation in high-fat diet fed mice. Acta Biochimica et Biophysica Sinica. 46(8). 675–681. 2 indexed citations
18.
Glinka, Yelena, et al.. (2011). Immunity against a therapeutic xenoprotein/Fc construct delivered by gene transfer is reduced through binding to the inhibitory receptor FcγRIIb. The Journal of Gene Medicine. 13(9). 470–477. 3 indexed citations
19.
Wang, Qinghua, Kui Chen, Rui Liu, et al.. (2010). Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist. PLoS ONE. 5(9). e12734–e12734. 39 indexed citations
20.
Wang, Qinghua, Weizhen Chen, & Ming Jen Tan. (2006). [Analysis of HLA-DRB1 allele polymorphism in the Fujian Han nationality population of China].. PubMed. 23(2). 240–1. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026